US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 58.415
- +0.535+0.92%
Trading Nov 21 14:16 ET
118.48BMarket Cap-16317P/E (TTM)
58.460High57.480Low3.90MVolume58.090Open57.880Pre Close226.57MTurnover0.19%Turnover Ratio15.13P/E (Static)2.03BShares61.08052wk High6.91P/B118.26BFloat Cap38.43652wk Low2.40Dividend TTM2.02BShs Float75.083Historical High4.11%Div YieldTTM1.69%Amplitude7.783Historical Low58.036Avg Price1Lot Size
Bristol-Myers Squibb Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 17.68%5.59B | 23.26%2.33B | -4.58%2.83B | 6.08%13.86B | 28.61%4.25B | 28.86%4.75B | -16.54%1.89B | -22.09%2.97B | -19.38%13.07B | -18.51%3.31B |
| Net income from continuing operations | -37.18%1.22B | -18.92%1.68B | -625.28%-11.91B | 26.71%8.04B | -12.99%1.76B | 20.27%1.93B | 45.35%2.08B | 76.70%2.27B | -9.54%6.35B | -14.63%2.03B |
| Operating gains losses | -35.14%-300M | -128.48%-377M | -879.49%-382M | -176.34%-724M | 26.96%-298M | -14.43%-222M | -298.80%-165M | -115.18%-39M | 81.67%-262M | -265.18%-408M |
| Depreciation and amortization | 6.45%2.59B | 6.74%2.6B | 4.24%2.53B | -5.02%9.76B | -2.26%2.46B | -5.91%2.44B | -5.85%2.43B | -6.00%2.43B | -3.84%10.28B | -2.25%2.52B |
| Deferred tax | 21.71%-256M | 69.52%-331M | -29.74%-711M | -20.09%-3.29B | -112.66%-1.33B | 49.30%-327M | -38.87%-1.09B | 20.23%-548M | -96.55%-2.74B | 50.71%-624M |
| Other non cash items | 4.58%365M | -10.34%130M | 16,318.99%12.97B | 16.86%1.21B | 566.67%640M | 3,590.00%349M | -60.06%145M | -86.59%79M | 29.75%1.04B | 166.67%96M |
| Change In working capital | 486.60%1.71B | -39.47%-2.37B | 114.56%198M | 14.13%-1.91B | 286.68%855M | 77.44%291M | -8.07%-1.7B | -275.69%-1.36B | -76.76%-2.23B | -676.27%-458M |
| -Change in receivables | 367.61%661M | -1,467.69%-1.02B | 373.71%479M | -50.08%-995M | -379.25%-508M | 63.35%-247M | 90.28%-65M | -122.26%-175M | 37.10%-663M | 36.90%-106M |
| -Change in inventory | 14.84%-218M | -1,306.25%-225M | 22.70%-218M | -988.41%-751M | -380.49%-197M | -1,500.00%-256M | -23.08%-16M | -28,300.00%-282M | -630.77%-69M | 67.97%-41M |
| -Change in payables and accrued expense | -6.18%-722M | 3.59%-2.2B | 12.98%1.21B | 69.18%-405M | 310.17%1.49B | -183.33%-680M | -87.21%-2.28B | 25.41%1.07B | -60.64%-1.31B | -17,800.00%-708M |
| -Change in other working capital | 34.74%1.99B | 61.65%1.08B | 35.51%-1.27B | 229.51%237M | -81.86%72M | 34.73%1.47B | 102.13%665M | 1.45%-1.97B | -130.60%-183M | 70.39%397M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 17.68%5.59B | 23.26%2.33B | -4.58%2.83B | 6.08%13.86B | 28.61%4.25B | 28.86%4.75B | -16.54%1.89B | -22.09%2.97B | -19.38%13.07B | -18.51%3.31B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 46.59%-219M | -300.91%-1.32B | -9,241.90%-19.62B | -116.10%-2.3B | -210.96%-1.35B | 80.30%-410M | -13.84%-329M | -321.05%-210M | -97.40%-1.06B | 202.49%1.21B |
| Capital expenditure reported | 5.26%-324M | -1.16%-262M | -2.16%-284M | -8.14%-1.21B | 4.62%-330M | -38.46%-342M | 4.78%-259M | -9.88%-278M | -14.90%-1.12B | -8.13%-346M |
| Net business purchase and sale | -17.72%-93M | -11,130.00%-1.1B | -13,396.64%-19.81B | 91.28%-260M | -190.91%-340M | 97.40%-79M | 103.64%10M | 472.50%149M | -245.82%-2.98B | 1,338.46%374M |
| Net investment purchase and sale | 1,700.00%198M | 157.50%46M | 690.12%478M | -127.20%-826M | -157.05%-676M | -99.09%11M | -131.01%-80M | -120.88%-81M | 134.16%3.04B | 70.50%1.19B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 46.59%-219M | -300.91%-1.32B | -9,241.90%-19.62B | -116.10%-2.3B | -210.96%-1.35B | 80.30%-410M | -13.84%-329M | -321.05%-210M | -97.40%-1.06B | 202.49%1.21B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 25.35%-3.85B | -85.14%-4.02B | 580.13%14.64B | 44.49%-9.42B | 129.79%967M | -13.58%-5.16B | 38.27%-2.17B | 46.05%-3.05B | -4.55%-16.96B | 18.17%-3.25B |
| Net issuance payments of debt | -26,420.00%-2.65B | -2,158.06%-2.8B | 1,155.09%15.95B | 108.59%456M | 1,445.59%2.1B | 99.65%-10M | 95.55%-124M | -859.80%-1.51B | 14.09%-5.31B | 219.30%136M |
| Net common stock issuance | --0 | --0 | --0 | 35.57%-5.16B | --0 | -583.76%-4B | ---905M | 95.00%-250M | -27.26%-8B | 12.18%-2.42B |
| Cash dividends paid | -2.10%-1.22B | -1.67%-1.22B | -1.34%-1.21B | -2.37%-4.74B | -1.31%-1.16B | -3.21%-1.19B | -4.09%-1.2B | -0.93%-1.2B | -5.41%-4.63B | -4.19%-1.15B |
| Proceeds from stock option exercised by employees | -60.98%16M | -111.32%-6M | -5.43%-97M | -97.26%27M | -86.03%25M | -22.64%41M | -87.35%53M | -127.63%-92M | 53.51%984M | --179M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 25.35%-3.85B | -85.14%-4.02B | 580.13%14.64B | 44.49%-9.42B | 129.79%967M | -13.58%-5.16B | 38.27%-2.17B | 46.05%-3.05B | -4.55%-16.96B | 18.17%-3.25B |
| Net cash flow | ||||||||||
| Beginning cash position | -25.27%6.3B | 3.16%9.33B | 23.53%11.52B | -34.86%9.33B | -4.89%7.57B | -23.13%8.43B | -28.07%9.05B | -34.86%9.33B | -4.39%14.32B | -42.67%7.96B |
| Current changes in cash | 285.59%1.52B | -390.41%-3.02B | -637.93%-2.14B | 143.34%2.15B | 204.24%3.87B | 72.11%-819M | 60.27%-615M | 83.39%-290M | -793.33%-4.96B | 159.27%1.27B |
| Effect of exchange rate changes | 302.63%77M | -175.00%-22M | -446.15%-45M | 236.36%45M | -17.89%78M | 42.42%-38M | 88.73%-8M | 44.44%13M | 67.65%-33M | 275.93%95M |
| End cash Position | 4.29%7.89B | -25.27%6.3B | 3.16%9.33B | 23.53%11.52B | 23.53%11.52B | -4.89%7.57B | -23.13%8.43B | -28.07%9.05B | -34.86%9.33B | -34.86%9.33B |
| Free cash flow | 19.46%5.27B | 26.78%2.06B | -5.27%2.55B | 5.88%12.65B | 32.50%3.92B | 28.17%4.41B | -18.15%1.63B | -24.36%2.69B | -21.57%11.95B | -20.79%2.96B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
